This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Albert Einstein College of Medicine, Industrial Research Limited, Victoria Link Limited. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wellington, NZ (2014)
- Porirua, NZ (2022)
Company Filing History:
2 out of 514 
1 out of 77 
1 out of 53 Years Active: 2014-2022
Title: Anthony David Woolhouse: A Pioneer in Anticancer Therapeutics
Introduction
Anthony David Woolhouse is an innovative inventor based in Wellington, New Zealand, known for his significant contributions to the field of medical research and therapeutic development. With two patents to his name, Woolhouse has focused his work on critical areas of cancer treatment and other diseases. His inventions have the potential to make impactful contributions in the realm of pharmaceuticals.
Latest Patents
Woolhouse's most recent patents showcase his dedication to advancing cancer therapies. One of his notable inventions is titled "Inhibitors of DNMT1 as anticancer therapeutic agents." This patent includes inhibitors of DNA methyltransferase 1, an enzyme essential for maintaining DNA CpG methylation marks in human cells. The invention outlines compounds, pharmaceutical compositions, and methods for effectively inhibiting DNMT1, marking a significant stride in anticancer research.
Another significant patent by Woolhouse is for "Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases." This invention describes compounds that act as inhibitors of purine nucleoside phosphorylases and nucleoside hydrolases, emphasizing their potential use in treating cancer, bacterial infections, and other diseases. The patent also includes pharmaceutical compositions containing these compounds, highlighting their therapeutic applications.
Career Highlights
Anthony David Woolhouse has had a distinguished career, during which he has collaborated with esteemed institutions. Notably, he has worked with the Albert Einstein College of Medicine, where he contributed to groundbreaking research in medicine. Additionally, Woolhouse collaborated with Industrial Research Limited, an organization known for its innovative approaches in various scientific fields.
Collaborations
Throughout his career, Woolhouse has partnered with notable colleagues, including Shivali Ashwin Gulab and Vern L Schramm. These collaborations have contributed to the depth and effectiveness of his research, leading to patents that push the boundaries of current medical treatment options.
Conclusion
With his innovative patents and collaborative spirit, Anthony David Woolhouse stands as a notable figure in the field of medical research. His work on inhibitors for DNMT1 and nucleoside phosphorylases showcases his commitment to finding solutions to pressing health challenges. As research continues to advance, Woolhouse's contributions will undoubtedly promote further innovations in therapeutic agents and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile